The Potency of a Combined Diclofenac-Ampiclox against Streptococcus Pyogen Isolated
from Patients with Pharyngitis: A pilot study
AuthorsRana Talib Al-Nafakh, Hussein Abdulkadhim
2
, and Naser A Naser
JournalAnnals of Tropical Medicine & Public Health
AbstractAbstract
Background: Pharyngitis, scarlet fever, and rheumatic fever are of the major infectious problems
caused by Streptococcus pyogen. Emergence of antibiotic- resistant strains makes such infection, its
rheumatic valvular disease, and glomerulonephritis complications a serious clinical challenge
especially in children.
Aims and objectives: In a maneuver of overcoming S. pyogen resistance and improve its response to
antibiotic, a no steroidal anti-inflammatory drug NSAID is repurposed as antimicrobial against S.
pyogen. In intention to be combined with the classical antibiotic recommended by WHO guideline of
care. The combination was assessed for its MIC and combination index against S. pyogen.
Materials and Methods: A multidrug-resistant strain of S. pyogen was isolated from patients,
suffering pharyngitis. The most serious isolate was cultivated for MIC determination of ampicloxdiclofenac combination in comparison with each alone to determine the combination index.
Results and conclusions: There was a significant synergism between ampiclox-diclofenac (index ˂ 1)
at P= 0.012 and Z score= 2.3 further confirmation of MIC folds of dilutions are to be assessed to obtain
reasonable evidence.
Recommendations: We recommended to further confirm the antistreptococcal effect of the combined
ampiclox-diclofenac on more dilutions of MIC assay and to analyze data of this combination in patients
with S. pyogen pharyngitis.
Assessment of Anticancer Effects of the Investigational Agent MEX2R
as K-RAS Oncogene Blocker in Human Colorectal Cancer Cells Model
SW480 Cell Line
AuthorsZahraa Fathi Sharba, Hussein Abdul Kadim A1
, Kifah Jabbar Alyaqubi2
and Hamid Naji Obied3
JournalInternational Journal of Medical Research &
Health Sciences, 2018, 7(12): 24-30
AbstractABSTRACT
Objective: To survey K-RAS blocker of choice among a group of inhibitors with characterizing their safety profile
in colorectal carcinoma. An experimental model of continuous SW480 cell line and Vero cell line was applied, in
vitro assessment by using tissue culture as a standard technique for checking the cytotoxicity of many compounds
and in development of new drugs. Materials and methods: This study tested the cytotoxicity assay of MEX2R and
chemotherapy (methotrexate) as comparative agents in the mechanism of action with the tested drug by Crystal Violet
assay (CV). After exposure both SW480 cell line and Vero cell line were treated first to different concentrations of
MEX2R compound (15.625, 31.25, 62.5, 125, 250 and 500) μg/ml for 36 hours and secondly to different concentrations
of methotrexate (15.625, 31.25, 62.5, 125, 250 and 500) μg/ml for 36 hours. Results: The results showed that the
investigational agent MEX2R exhibits highly significant cytotoxic effects (p ≤ 0.05) in SW480 colorectal cancer
cells when compared with control (untreated cells), and less cytotoxic influences on normal Vero cell line in a dosedependent manner. The tested drugs showed anticancer activity with half maximal growth inhibitory concentrations
(IC50) for MEX2R 65.738 μg/ml which was more potent than antitumor drugs methotrexate (MTX) that has cell
cycle arrest activity like investigational agent’s action, IC50 of MTX was about 93.574 μg/ml. The selectivity index of
MEX2R compound (3.252) was higher than the selectivity index of MTX (2.65). Conclusion: From the overall results,
MEX2R has highly significant cytotoxic effects on SW480 colorectal cancer cell line when compared with MTX, also
MEX2R agent possessed safe profiles in Vero cell line as normal cells in comparison with standard chemotherapy
MTX
CYTOTOXIC ACTIVITY OF COMPOUNDED ANTHRACYCLINE
AGAINST RHABDOMYOSARCOMA CANCER CELL LINE
AuthorsMerza Hemza Homady, Hussein Abdul Kadhim2
, Khalida K. Abbas Al-Kelaby3
, Dhifaf Zeki Aziz1
*
and Naser Jawad Kadhim1
JournalPlant Archives Vol. 18
AbstractHigh selectivity of Cytotoxic Activity of Compounded Anthracycline against Rhabdomyosarcoma Cancer Cell Line that
effect of DMT between cancer cell and normal cell line increase the prospects that this compound could serve as leads for
novel anticancer drugs and hence may be potential candidates for use in human cancer therapy, however, further investigations
will be required in this regard to validate this hypothesis.
Key words : Cytotoxic activity, anthracycline, human cancer therapy, anticancer drugs.
ASSESSMENT OF COMPOUNDED DOXORUBICIN IN CARDIAC TISSUE OF
EXPERIMENTAL ANIMALS
AuthorsDhifaf Zeki Aziz, Merza Hemza Homady1
, Hussein Abdul Kadim2
, Khalida K. Abbas Al-Kelaby3
JournalPak.J. Biotechnol. Vol. 14 (4) 811-816 (2017)
AbstractDoxorubicin is one of the most important anticancer agents, but its clinical uses are limited due to
cardiotoxicity, the present study evaluated the effects of new derivatives of doxorubicin on cardiac tissue by the
measurement of serum cardiac troponin I (cTnI) and CK-BM assays as biomarkers as well as heart tissue after 3
weeks of treatment in albino mice. The results indicated that TnI was significantly elevated (P≤ 0.05) in all studied
groups when compared with the control, also serum CK-MB was significantly elevated (P≤ 0.05) in all studied groups
except that treated with a new compound when compared with the control group. The histopathological study of heart
tissue revealed that the treatment with this compound showed less changes in heart tissue.